S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Profit From the Commercial Solar Boom? (Ad)
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Profit From the Commercial Solar Boom? (Ad)
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Daqo New Energy Charged Up For New Highs
Profit From the Commercial Solar Boom? (Ad)
TG Therapeutics Stock 300% Rally Has Legs Yet
How major US stock indexes fared Wednesday 2/7/2023
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Profit From the Commercial Solar Boom? (Ad)
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Profit From the Commercial Solar Boom? (Ad)
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Daqo New Energy Charged Up For New Highs
Profit From the Commercial Solar Boom? (Ad)
TG Therapeutics Stock 300% Rally Has Legs Yet
How major US stock indexes fared Wednesday 2/7/2023
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Profit From the Commercial Solar Boom? (Ad)
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Profit From the Commercial Solar Boom? (Ad)
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Daqo New Energy Charged Up For New Highs
Profit From the Commercial Solar Boom? (Ad)
TG Therapeutics Stock 300% Rally Has Legs Yet
How major US stock indexes fared Wednesday 2/7/2023
S&P 500   4,117.86
DOW   33,949.01
QQQ   304.37
Is SoundHound Voice AI the Next Big Thing?
Profit From the Commercial Solar Boom? (Ad)
CVS Health Corporation Is Coiled And Ready To Spring Higher 
Double Meat: Beyond Meat Could Be 2023’s Next Two-Bagger
Profit From the Commercial Solar Boom? (Ad)
V.F. Corporation Is A High-Yield Bargain Despite Dividend Cut
Daqo New Energy Charged Up For New Highs
Profit From the Commercial Solar Boom? (Ad)
TG Therapeutics Stock 300% Rally Has Legs Yet
How major US stock indexes fared Wednesday 2/7/2023
NASDAQ:ADMP

Adamis Pharmaceuticals - ADMP Stock Forecast, Price & News

$0.22
+0.01 (+4.76%)
(As of 02/8/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.21
$0.23
50-Day Range
$0.14
$0.23
52-Week Range
$0.12
$0.73
Volume
359,124 shs
Average Volume
452,698 shs
Market Capitalization
$33.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ADMP stock logo

About Adamis Pharmaceuticals (NASDAQ:ADMP) Stock

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.

Receive ADMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADMP Stock News Headlines

YIKES! 220 Pounds of Graphite in Each EV Battery?
Most don't know that today's EV batteries contain more graphite than any other essential ingredient... more than lithium, copper or aluminum! The megatrend of electrifying vehicles only adds to graphite demand, expected to skyrocket 1,050% by 2030. Investors have been frustrated in their search for a Made In America solution – until now.
Adamis Pharmaceuticals Co. (NASDAQ:ADMP) Short Interest Update
The Lithium "Lie"
Did you know each electric car battery requires 220 pounds of graphite – more than lithium, copper, or aluminum? China controls more than 90% of this vital ingredient. But the U.S. just classified graphite as "essential for America's National Defense"... and one little-known company is looking to win big in the energy war with China.
Adamis Announces Review of Strategic Alternatives
ADMP Adamis Pharmaceuticals Corporation
Adamis Pharmaceuticals Corporation
See More Headlines
Receive ADMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adamis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADMP Company Calendar

Last Earnings
11/14/2022
Today
2/09/2023
Next Earnings (Estimated)
3/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ADMP
Fax
N/A
Employees
116
Year Founded
N/A

Profitability

Net Income
$-45,830,000.00
Pretax Margin
-2,069.43%

Debt

Sales & Book Value

Annual Sales
$2.21 million
Book Value
$0.17 per share

Miscellaneous

Free Float
148,033,000
Market Cap
$33.00 million
Optionable
Optionable
Beta
1.32

Key Executives

  • David J. Marguglio
    President, Chief Executive Officer & Director
  • David C. Benedicto
    Chief Financial & Accounting Officer
  • Thomas H. Moll
    Vice President-Research













ADMP Stock - Frequently Asked Questions

How have ADMP shares performed in 2023?

Adamis Pharmaceuticals' stock was trading at $0.1693 at the beginning of 2023. Since then, ADMP stock has increased by 29.9% and is now trading at $0.22.
View the best growth stocks for 2023 here
.

Are investors shorting Adamis Pharmaceuticals?

Adamis Pharmaceuticals saw a decrease in short interest in the month of January. As of January 15th, there was short interest totaling 1,910,000 shares, a decrease of 23.9% from the December 31st total of 2,510,000 shares. Based on an average daily trading volume, of 754,700 shares, the short-interest ratio is presently 2.5 days.
View Adamis Pharmaceuticals' Short Interest
.

When is Adamis Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023.
View our ADMP earnings forecast
.

How were Adamis Pharmaceuticals' earnings last quarter?

Adamis Pharmaceuticals Co. (NASDAQ:ADMP) posted its earnings results on Monday, November, 14th. The specialty pharmaceutical company reported ($0.03) earnings per share (EPS) for the quarter. The specialty pharmaceutical company earned $1.51 million during the quarter.

What other stocks do shareholders of Adamis Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Adamis Pharmaceuticals investors own include Trevena (TRVN), Amarin (AMRN), Sorrento Therapeutics (SRNE), Verastem (VSTM), Dynavax Technologies (DVAX), Novavax (NVAX), SCYNEXIS (SCYX), Synergy Pharmaceuticals (SGYP), Agile Therapeutics (AGRX) and OPKO Health (OPK).

What is Adamis Pharmaceuticals' stock symbol?

Adamis Pharmaceuticals trades on the NASDAQ under the ticker symbol "ADMP."

Who are Adamis Pharmaceuticals' major shareholders?

Adamis Pharmaceuticals' stock is owned by many different retail and institutional investors. Top institutional shareholders include Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include David C Benedicto, David J Marguglio, Dennis J Phd Carlo, Karen K Daniels, Robert O Hopkins and Ronald B Moss.
View institutional ownership trends
.

How do I buy shares of Adamis Pharmaceuticals?

Shares of ADMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Adamis Pharmaceuticals' stock price today?

One share of ADMP stock can currently be purchased for approximately $0.22.

How much money does Adamis Pharmaceuticals make?

Adamis Pharmaceuticals (NASDAQ:ADMP) has a market capitalization of $33.00 million and generates $2.21 million in revenue each year.

How many employees does Adamis Pharmaceuticals have?

The company employs 116 workers across the globe.

How can I contact Adamis Pharmaceuticals?

Adamis Pharmaceuticals' mailing address is 11682 EL CAMINO REAL SUITE 300, SAN DIEGO CA, 92130. The official website for the company is www.adamispharmaceuticals.com. The specialty pharmaceutical company can be reached via phone at (858) 997-2400 or via email at mflather@adamispharma.com.

This page (NASDAQ:ADMP) was last updated on 2/9/2023 by MarketBeat.com Staff